|
|
|
|
|
|
||||
| By Year | By Month | By Week | Today | Search | Jump to month | ||||
|
|
|||||||||
Targeting MTH1 for de-personalised anti-cancer treatment |
|
|||
|
|
||||
|
||||
Thomas HelledayDepartment of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden Host: Giulio Superti-Furga
|
||||
|
Location : CeMM Building, seminar room level 8, Vienna Contact : CeMMinar |
||||
Export Event 
